180778-08-9

Upstream product

• 1025807-18-4 3,6-Dimethoxy-2,4-dimethyl-phenol 
• 31404-86-1 2,4-dimethyl-3,6-dimethoxybenzaldehyde 

Downstream Products

• 144562-66-3 2-[1-(3-Butoxy-2,5-dimethoxy-4,6-dimethyl-phenyl)-meth-(E)-ylidene]-5-pyridin-3-yl-pentanoic acid ethyl ester 
• 144562-65-2 2-[1-(3-Butoxy-2,5-dimethoxy-4,6-dimethyl-phenyl)-meth-(E)-ylidene]-7-pyridin-3-yl-heptanoic acid ethyl ester 
• 144562-82-3 (E)-3-[3-(n-butyloxy)-2,5-dimethoxy-4,6-dimethylphenyl]-2-[5-(3-pyridyl)pentyl]-2-propenoic acid 
• 144562-83-4 (E)-3-[3-(n-butyloxy)-2,5-dimethoxy-4,6-dimethylphenyl]-2-[3-(3-pyridyl)propyl]-2-propenoic acid 

Relevant academic research and scientific papers

Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3- pyridyl)alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetase

As part of our research for the development of novel antiinflammatory drug candidates, we have designed and synthesized a series of (E)-3-(1,4- benzoquinonyl)-2-[(3-pyridyl)alkyl]-2-propenoic acid derivatives as dual inhibitors of 5-lipoxygenase (5-LO) an